Number of the records: 1
Immunocomplexes of IL-2 and Anti-IL-2 mAB as novel promising tool for cancer immunotherapy or combined chemo/immunotherapy
- 1.0099653 - MBÚ 2008 RIV GB eng C - Conference Paper (international conference)
Kovář, Marek - Tomala, Jakub - Chmelová, H. - Strohalm, Jiří - Etrych, Tomáš - Ulbrich, Karel - Říhová, Blanka
Immunocomplexes of IL-2 and Anti-IL-2 mAB as novel promising tool for cancer immunotherapy or combined chemo/immunotherapy.
[IL-2 a anti-IL-2 mAb jako nový nástroj pro imunoterapii a/nebo kombinovanou chemoterapii.]
Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2007 /35./. London: Karger, 2007, s. 85-85. ISSN 1010-4283. E-ISSN 1423-0380.
[Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2007 /35./. Prague (CZ), 15.09.2007-19.09.2007]
R&D Projects: GA ČR GP301/07/P192
Institutional research plan: CEZ:AV0Z50200510; CEZ:AV0Z40500505
Keywords : doxorubicin
Subject RIV: EC - Immunology
We have studies a novel approach to effectively use IL-2 in cancer immunotherapy. Using IL-2/anti-IL-2 mAb immunocomplexes seems to be a promising way to enhance anti-tumor acitivity of IL-2 in vivo
Studovali jsme zcela nový způosb efektivního použití IL-2 v nádorové imunoterapii. Prokázali jsme, že imunokomplexy IL-2 a anti-IL-2 mAb mají podstatně vyšší protinádorovou aktivitu in vivo než volný Il-2
Permanent Link: http://hdl.handle.net/11104/0158204
Number of the records: 1